Ompenaclid drug page Clinical trials

Trials with Ompenaclid

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
0Recruiting
4Countries
159Planned patients

Showing 1–2 of 2

A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer
Finished Phase 2 70 patients NCT05983367

The purpose of this study is to measure tumor response to treatment with ompenaclid (RGX-202-01) in patients with previously treated RAS mutant advanced or metastatic CRC. All patients will receive treatment with FOLFIRI and bevacizumab. I…

Belgium, France, Spain Oct 2023 – Mar 2025 Interventional
A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer
Finished Phase 1 89 patients NCT03597581

This is a Phase 1 study currently evaluating PO administered ompenaclid in combination with FOLFIRI and bevacizumab in patients with advanced (i.e., locally advanced and unresectable, or metastatic) previously treated colorectal adenocarci…

United States Jun 2018 – Mar 2025 Interventional